Mikael Dolsten Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mikael Dolsten.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mikael Dolsten. Mikael Dolsten is Sr. VP & Pres., Wyeth Research in WYETH ($WYE) and President R&D in PFIZER INC ($PFE) and Director in Karyopharm Therapeutics Inc. ($KPTI).

Latest Insider Trading Transactions of Mikael Dolsten

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, KPTI, PFE, WYE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 21 2021KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA9.4223,900225,13823,900
Mar 01 2021PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA33.82182,0506,156,931182,050
Mar 01 2021PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA33.82210,6977,125,773210,697
Mar 01 2021PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF33.8228,271956,125156,568184.8 K to 156.6 K (-15.29 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.7924,242916,105174,918199.2 K to 174.9 K (-12.17 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.7817,357655,747199,160216.5 K to 199.2 K (-8.02 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.8016,840636,552216,517233.4 K to 216.5 K (-7.22 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.7714,727556,239233,357248.1 K to 233.4 K (-5.94 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.759,700366,175248,084257.8 K to 248.1 K (-3.76 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.816,470244,631257,784264.3 K to 257.8 K (-2.45 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.765,517208,322264,254269.8 K to 264.3 K (-2.05 %)
May 19 2020PFEPFIZER INCDolsten MikaelPresident R&DSellS37.8250018,910269,771270.3 K to 269.8 K (-0.18 %)
Mar 03 2020PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF33.4239,4461,318,285268,515308 K to 268.5 K (-12.81 %)
Feb 28 2020PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.10182,4616,221,920182,461
Feb 28 2020PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.10212,9617,261,970212,961
Feb 28 2020PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.7222,314774,742307,961330.3 K to 308 K (-6.76 %)
Feb 28 2020PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.7215,478537,396330,275345.8 K to 330.3 K (-4.48 %)
Feb 28 2020PFEPFIZER INCDolsten MikaelPresident R&DGrantA0.0045,5660345,753300.2 K to 345.8 K (+15.18 %)
Jun 07 2019KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA5.4325,000135,75025,000
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM32.23126,3664,072,7760
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM30.59155,1724,746,7110
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.5238,6451,681,830289,126327.8 K to 289.1 K (-11.79 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.533,250141,473327,771331 K to 327.8 K (-0.98 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.542,600113,204331,021333.6 K to 331 K (-0.78 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.552,400104,520333,621336 K to 333.6 K (-0.71 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.562,18795,266336,021338.2 K to 336 K (-0.65 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.5677,4843,375,203338,208415.7 K to 338.2 K (-18.64 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.5714,760643,093415,692430.5 K to 415.7 K (-3.43 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.585,927258,299430,452436.4 K to 430.5 K (-1.36 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DSellS43.592,300100,257436,379438.7 K to 436.4 K (-0.52 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DBuyM32.2348,5821,565,798438,679390.1 K to 438.7 K (+12.45 %)
Mar 05 2019PFEPFIZER INCDolsten MikaelPresident R&DBuyM30.5957,6091,762,259390,097332.5 K to 390.1 K (+17.33 %)
Mar 01 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA43.35126,7625,495,133126,762
Mar 01 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA43.35150,4196,520,664150,419
Mar 01 2019PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF42.9347,1012,022,046332,488379.6 K to 332.5 K (-12.41 %)
Mar 01 2019PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF42.9326,6721,145,029379,589406.3 K to 379.6 K (-6.57 %)
Mar 01 2019PFEPFIZER INCDolsten MikaelPresident R&DGrantA0.0096,1830406,261310.1 K to 406.3 K (+31.02 %)
Feb 26 2019PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF42.9654,5682,344,241310,078364.6 K to 310.1 K (-14.96 %)
Feb 01 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM27.37164,5344,503,2960
Feb 01 2019PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM34.59144,9285,013,0600
Feb 01 2019PFEPFIZER INCDolsten MikaelPresident R&DBuyM34.5942,0611,454,890362,051320 K to 362.1 K (+13.14 %)
Feb 01 2019PFEPFIZER INCDolsten MikaelPresident R&DBuyM27.3783,9072,296,535319,990236.1 K to 320 K (+35.54 %)
Sep 17 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM32.23158,6625,113,6760
Sep 17 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM21.03185,1853,894,4410
Sep 17 2018PFEPFIZER INCDolsten MikaelPresident R&DBuyM32.2357,2111,843,911234,299177.1 K to 234.3 K (+32.31 %)
Sep 17 2018PFEPFIZER INCDolsten MikaelPresident R&DBuyM21.03124,5012,618,256177,08852.6 K to 177.1 K (+236.75 %)
Aug 14 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseI0.0024,5040100,677
Jun 20 2018KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA18.8017,000319,60017,000
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.6132,4571,188,25151,18583.6 K to 51.2 K (-38.80 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.5615,459565,18183,64299.1 K to 83.6 K (-15.60 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.609,900362,34099,101109 K to 99.1 K (-9.08 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.595,300193,927109,001114.3 K to 109 K (-4.64 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.574,154151,912114,301118.5 K to 114.3 K (-3.51 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.552,32985,125118,455120.8 K to 118.5 K (-1.93 %)
Mar 12 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS36.581003,658120,784120.9 K to 120.8 K (-0.08 %)
Mar 05 2018PFEPFIZER INCDolsten MikaelPresident R&DSellS35.8513,986501,398120,884134.9 K to 120.9 K (-10.37 %)
Mar 02 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM27.37198,2385,425,7740
Mar 02 2018PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF35.70120,3304,295,781134,870255.2 K to 134.9 K (-47.15 %)
Mar 02 2018PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF36.3138,1521,385,299255,200293.4 K to 255.2 K (-13.01 %)
Mar 02 2018PFEPFIZER INCDolsten MikaelPresident R&DBuyM27.37198,2385,425,774293,35295.1 K to 293.4 K (+208.42 %)
Feb 27 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM18.90174,0813,290,1310
Feb 27 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseI0.0016,5470123,093
Feb 27 2018PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF35.9855,5441,998,473115,772171.3 K to 115.8 K (-32.42 %)
Feb 27 2018PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF36.2653,9491,956,191171,316225.3 K to 171.3 K (-23.95 %)
Feb 27 2018PFEPFIZER INCDolsten MikaelPresident R&DBuyM18.90174,0813,290,131225,26551.2 K to 225.3 K (+340.11 %)
Feb 23 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA35.74120,7924,317,106120,792
Feb 23 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA35.74120,7924,317,106120,792
Feb 23 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA35.74144,4855,163,894144,485
Feb 23 2018PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA35.74144,4855,163,894144,485
Jun 19 2017PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseI0.0016,6820135,956
Jun 16 2017KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA9.1817,000156,06017,000
Mar 03 2017PFEPFIZER INCDolsten MikaelPresident R&DSellS34.5515,401532,10549,31864.7 K to 49.3 K (-23.80 %)
Mar 03 2017PFEPFIZER INCDolsten MikaelPresident R&DSellS34.4815,569536,81964,71980.3 K to 64.7 K (-19.39 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DSellS34.2627,523942,93880,288107.8 K to 80.3 K (-25.53 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DSellS34.2724,668845,372107,811132.5 K to 107.8 K (-18.62 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.2816,581568,397132,479149.1 K to 132.5 K (-11.12 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.2816,400562,192149,060165.5 K to 149.1 K (-9.91 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DSellS34.256,655227,934165,460172.1 K to 165.5 K (-3.87 %)
Mar 01 2017PFEPFIZER INCDolsten MikaelPresident R&DGrantA0.0031,8000172,115140.3 K to 172.1 K (+22.66 %)
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.06121,2944,131,274121,294
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.06146,1044,976,302146,104
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM21.03218,4474,593,9400
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF32.49105,7613,436,175140,315246.1 K to 140.3 K (-42.98 %)
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.0653,8391,833,756246,076299.9 K to 246.1 K (-17.95 %)
Feb 27 2017PFEPFIZER INCDolsten MikaelPresident R&DBuyM21.03218,4474,593,940299,91581.5 K to 299.9 K (+268.14 %)
Nov 16 2016PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseI0.00149,7470149,747
Jun 17 2016KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA8.0610,00080,60010,000
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.4528,435951,151370,619399.1 K to 370.6 K (-7.13 %)
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.4715,000502,050399,054414.1 K to 399.1 K (-3.62 %)
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.4614,000468,440414,054428.1 K to 414.1 K (-3.27 %)
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.489,900331,452428,054438 K to 428.1 K (-2.26 %)
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.481535,122437,954438.1 K to 438 K (-0.03 %)
May 05 2016PFEPFIZER INCDolsten MikaelPresident R&DSellS33.491003,349438,107438.2 K to 438.1 K (-0.02 %)
Mar 01 2016PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF30.239,549288,666435,210444.8 K to 435.2 K (-2.15 %)
Mar 01 2016PFEPFIZER INCDolsten MikaelPresident R&DGrantA0.0018,5300444,759426.2 K to 444.8 K (+4.35 %)
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA30.59138,6754,242,068138,675
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA30.59155,1724,746,711155,172
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM18.90210,2803,974,2920
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF29.6799,2232,943,946426,229525.5 K to 426.2 K (-18.88 %)
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF30.0252,4501,574,549525,452577.9 K to 525.5 K (-9.08 %)
Feb 26 2016PFEPFIZER INCDolsten MikaelPresident R&DBuyM18.90210,2803,974,292577,902367.6 K to 577.9 K (+57.20 %)
May 26 2015KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA26.1510,000261,50010,000
Apr 02 2015KPTIKaryopharm Therape ...Dolsten MikaelDirectorOption ExerciseA30.6120,000612,20020,000
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.4830,7001,058,536355,911386.6 K to 355.9 K (-7.94 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.477,939273,657386,611394.6 K to 386.6 K (-2.01 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.464,500155,070394,550399.1 K to 394.6 K (-1.13 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.443,659126,016399,050402.7 K to 399.1 K (-0.91 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.423,000103,260402,709405.7 K to 402.7 K (-0.74 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.412,50086,025405,709408.2 K to 405.7 K (-0.61 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.402,40082,560408,209410.6 K to 408.2 K (-0.58 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.432,00068,860410,609412.6 K to 410.6 K (-0.48 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.491,20041,388412,609413.8 K to 412.6 K (-0.29 %)
Mar 06 2015PFEPFIZER INCDolsten MikaelPresident R&DSellS34.4540013,780413,809414.2 K to 413.8 K (-0.10 %)
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.59120,8054,178,645120,805
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseA34.59144,9285,013,060144,928
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DOption ExerciseM17.69146,3962,589,7450
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF33.4757,6921,930,951414,209471.9 K to 414.2 K (-12.23 %)
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.6644,9151,556,754471,901516.8 K to 471.9 K (-8.69 %)
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DPayment of ExerciseF34.668,497294,506516,816525.3 K to 516.8 K (-1.62 %)
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DGrantA0.0023,0060525,313502.3 K to 525.3 K (+4.58 %)
Feb 27 2015PFEPFIZER INCDolsten MikaelPresident R&DBuyM17.69146,3962,589,745502,307355.9 K to 502.3 K (+41.13 %)
Oct 19 2009WYEWYETHDolsten MikaelSr. VP & Pres., Wye ...Option ExerciseD43.0852,0002,240,1600
Jun 18 2008WYEWYETHDolsten MikaelSr. VP & Pres., Wye ...Option ExerciseA43.0852,0002,240,16052,000

Page:   1